UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000018553
Receipt No. R000021399
Official scientific title of the study Efficiency of insulin-like growth factor 1 therapy for cerebral ischemia by cardiopulmonary arrest
Date of disclosure of the study information 2015/10/01
Last modified on 2016/04/02 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Efficiency of insulin-like growth factor 1 therapy for cerebral ischemia by cardiopulmonary arrest
Title of the study (Brief title) Efficiency of IGF-1 therapy for cerebral ischemia by CPA
Region
Japan

Condition
Condition Cerebral ischemia by cardiopulmonary arrest
Classification by specialty
Emergency medicine Intensive care medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Efficiency of insulin-like growth factor 1 therapy for cerebral ischemia by cardiopulmonary arrest
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Inhospital mortality
Key secondary outcomes Neurologic outcome

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 insulin-like growth factor 1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
15 years-old <
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria cardiopulmonary arrest
Key exclusion criteria trauma
Target sample size 30

Research contact person
Name of lead principal investigator Naoya Matsuda
Organization Yokohama City Minato Red Cross Hospital
Division name Emergency and critical care center
Address 3-12-1 Shinyamashita, Naka-ku, Yokohama city, Japan
TEL 045-628-6100
Email n.matsuda.shinshu@gmail.com

Public contact
Name of contact person Naoya Matsuda
Organization Yokohama City Minato Red Cross Hospital
Division name Emergency and critical care center
Address 3-12-1 Shinyamashita, Naka-ku, Yokohama city, Japan
TEL 045-628-6100
Homepage URL
Email n.matsuda.shinshu@gmail.com

Sponsor
Institute Emergency and critical care center
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization TEIJIN Pharma
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 横浜市立みなと赤十字病院(神奈川県)

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2015 Year 08 Month 05 Day
Anticipated trial start date
2015 Year 10 Month 01 Day
Last follow-up date
2016 Year 10 Month 01 Day
Date of closure to data entry
2016 Year 12 Month 31 Day
Date trial data considered complete
2016 Year 12 Month 31 Day
Date analysis concluded
2017 Year 03 Month 31 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 08 Month 05 Day
Last modified on
2016 Year 04 Month 02 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-bin/icdr_e/ctr_view.cgi?recptno=R000021399